Clinical Trial

Washed Microbiota Transplantation for Attention-deficit/Hyperactivity Disorder

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder characterized by inattention and hyperactivity-impulsivity. ADHD is often accompanied by oppositional defiant disorder and sleep disturbance, and can increase the risk of other psychiatric disorders, functional impairment in academic and occupational performance. Recently, gut microbiota has been implicated in the ADHD via gut-brain axis. In this study, investigators aimed to evaluate the efficacy of WMT for core ADHD symptoms and its comorbidities using specialized questionnaires for ADHD and investigate the underlying mechanism.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2024-04-16; most recent amendment 2025-09-03.
Status change: Not Yet Recruiting → Recruiting 2024-07-15
Trial Details
NCT Number NCT06376331
Lead Sponsor The Second Hospital of Nanjing Medical University
Collaborators: Nanjing Medical University
Conditions Attention-deficit/Hyperactivity Disorder
Enrollment 50 participants
Start Date 2024-04-28
Primary Completion 2027-06-01 (estimated)
Study Completion 2027-07-01 (estimated)
Updated on ClinicalTrials.gov 2025-09-05